Regulatory

RSS

FDA approves Xtandi for metastatic castration-resistant prostate cancer

Sep. 3, 2012

New drug approved for IBS-C and CIC

Aug. 31, 2012

Nucynta ER approved for new indication in U.S.

Aug. 30, 2012

European Commission approves Zinforo

Aug. 29, 2012

NeutroPhase cleared for use in new indications

Aug. 28, 2012

FDA approves new combination pill for HIV

Aug. 28, 2012

Growject approved for fourth indication in Japan

Aug. 24, 2012

FDA approves sNDA for Tradjenta

Aug. 20, 2012

Marqibo receives accelerated approval

Aug. 13, 2012

Japanese authorities grant new approval to ultrasound contrast agent

Aug. 10, 2012